Role and New Insights of Pirfenidone in Fibrotic Diseases.

Int J Med Sci · 2015 · PMC4643073 · PMID 26640402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The highly significant finding was supported by the encouraging effect on rates of death from any cause (4.0% vs. 7.2%) and from IPF (1.1% vs. 2.5%), since progression-free survival (PFS) was reduced with PFD (HR 0.57; 95% CI 0.43-0.77; P<0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.